The clinical effectiveness and cost-effectiveness of bariatric (weight loss) surgery for obesity: A systematic review and economic evaluation

Health Technology Assessment

Volumn 13, Issue 41, 2009, Pages

  Picot, J ^a   Jones, J ^a   Colquitt, J L ^a   Gospodarevskaya, E ^a   Loveman, E ^a   Baxter, L ^a   Clegg, A J ^a  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

RIMONABANT; SIBUTRAMINE; TETRAHYDROLIPSTATIN;

ACUTE CHOLECYSTITIS; ADJUSTABLE GASTRIC BANDING; AGE DISTRIBUTION; ANASTOMOSIS LEAKAGE; ANTHROPOMETRIC PARAMETERS; BARIATRIC SURGERY; BLOOD PRESSURE; BODY MASS; CARDIOVASCULAR RISK; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; COHORT ANALYSIS; COMORBIDITY; COST EFFECTIVENESS ANALYSIS; DATA EXTRACTION; DECISION MAKING; DISEASE CLASSIFICATION; ECONOMIC EVALUATION; FOLLOW UP; GASTRECTOMY; GASTROINTESTINAL DISEASE; HEALTH STATUS; HUMAN; ISCHEMIC HEART DISEASE; LAPAROSCOPIC ISOLATE SLEEVE GASTRECTOMY; LAPAROSCOPIC SURGERY; LIFE EXPECTANCY; LIFESPAN; LUNG EMBOLISM; MORBID OBESITY; MORBIDITY; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; OSTEOARTHRITIS; OUTCOME ASSESSMENT; PNEUMONIA; POPULATION; POSTOPERATIVE COMPLICATION; PREVALENCE; PROSPECTIVE STUDY; QUALITY CONTROL; QUALITY OF LIFE; RESPIRATORY TRACT DISEASE; REVIEW; SENSITIVITY ANALYSIS; SEXUAL DYSFUNCTION; STOMACH BYPASS; STOMACH SURGERY; STROKE; SURGICAL MORTALITY; SYSTEMATIC REVIEW; UNSPECIFIED SIDE EFFECT; VERTICAL BANDED GASTROPLASTY; WEIGHT CHANGE; WEIGHT REDUCTION; ADOLESCENT; ADULT; AGED; COST BENEFIT ANALYSIS; ECONOMICS; FEMALE; MALE; MIDDLE AGED; STANDARD; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BARIATRIC SURGERY; COST-BENEFIT ANALYSIS; FEMALE; HUMANS; MALE; MIDDLE AGED; OBESITY; OUTCOME ASSESSMENT (HEALTH CARE); YOUNG ADULT;

EID: 70349119432     PISSN: 13665278     EISSN: None     Source Type: Journal    
DOI: 10.3310/hta13410     Document Type: Review

References (197)

1. Walley AJ, Blakemore AIF, Froguel P. Genetics of obesity and the prediction of risk for health. Hum Mol Genet 2006;15:R124-R130.
2. Wilding JPH. Pathophysiology and aetiology of obesity. Medicine 2006;34:501-505
3. Rissanen A, Heliovaara M, Aromaa A. Overweight and anthropometric changes in adulthood: a prospective study of 17,000 Finns. Int J Obes 1988;12:391-401. (Pubitemid 18263507)
4. McTigue KM, Garrett JM, Popkin BM. The natural history of the development of obesity in a cohort of young U.S. adults between 1981 and 1998. Ann Intern Med 2002;136:857-864
5. Kahn HS, Cheng YJ. Longitudinal changes in BMI and in an index estimating excess lipids among white and black adults in the United States. Int J Obes (Lond) 2008;32:136-143
6. Gordon-Larsen P, Adair LS, Nelson MC, Popkin BM. Five-year obesity incidence in the transition period between adolescence and adulthood: the National Longitudinal Study of Adolescent Health. Am J Clin Nutr 2004;80:569-575 (Pubitemid 41115519)
7. World Health Organization. Physical status: the use and interpretation of anthropometry. Report of a WHO Expert Committee. World Health Organ Tech Rep Ser 1995;854:1-452.
8. World Health Organization. Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser 2000;894:i-253.
9. National Institute for Health and Clinical Excellence. Obesity - guidance on the prevention, identification, assessment and management of overweight and obesity in adults and children. London: The Stationery Office; 2006. Clinical Guideline 43.
10. Parikh NI, Pencina MJ, Wang TJ, Lanier KJ, Fox CS, D'Agostino RB, et al. Increasing trends in incidence of overweight and obesity over 5 decades. Am J Med 2007;120:242-250
11. Nafziger AN, Stenlund H, Wall S, Jenkins PL, Lundberg V, Pearson TA, et al. High obesity incidence in northern Sweden: how will Sweden look by 2009? Eur J Epidemiol 2006;21:377-382
12. World Health Organization. Overweight and obesity. Factsheet no.311. Geneva: World Health Organization; 2006.
13. Craig R, Mindell J, editors. Health survey for England 2006. Latest trends. A survey carried out for NHS The Information Centre; 2006.
14. Issued by Statistical Directorate WAG. Welsh health survey 2007. Cardiff: Welsh Assembly Government; 2008.
15. Clegg AJ, Colquitt J, Sidhu MK, Royle P, Loveman E, Walker A. The clinical effectiveness and cost-effectiveness of surgery for people with morbid obesity: a systematic review and economic evaluation. Health Technol Assess 2002;6:1-153.
16. National Statistics TIC. Statistics on obesity, physical activity and diet: England, January 2008. Leeds: The Information Centre; 2008.
17. National Centre for Social Research. Health survey for England, 2003. Commissioned by the Department of Health. http://www.dh.gov.uk/en/ Publicationsandstatistics/Publications/PublicationsStatistics/DH-4098712.
18. Zaninotto P, Wardle H, Stamatakis E, Mindell J, Head J. Forecasting obesity to 2010. Joint Health Surveys Unit, National Centre for Social Research, Department of Epidemiology and Public Health at the Royal Free and University College Medical School; 2006.
19. Welsh Assembly Government. Health Statistics Wales, 2008. Cardiff: WAG; 2008.
20. McPherson K, Marsh T, Brown M. Foresight. Tackling obesities: future choices - modelling future trends in obesity and the impact on health, 2nd edn. London: Government Office for Science; 2007.
21. Lobstein T, Leach R. Foresight. Tackling obesities: future choices - international comparisons of obesity trends, determinants and responses - evidence review. London: Government Office for Science; 2007.
22. Boddy LM, Hackett AF, Stratton G, Taylor SR. Effect on prevalence rates of using three different definitions of obesity in 9-10 year old children. Int J Hlth Promotion Educ 2007;45:11-16. (Pubitemid 46358685)
23. Frost GS, Lyons GF, Counterweight Project Team. Obesity impacts on general practice appointments. Obes Res 2005;13:1442-1449
24. Report By The Comptroller and Auditor General. Tackling obesity in England. London: The Stationery Office; 2001.
25. Peeters A, Barendregt JJ, Willekens F, Mackenbach JP, Al MA, Bonneux L. Obesity in adulthood and its consequences for life expectancy: a life-table analysis. Ann Intern Med 2003;138:24-32. (Pubitemid 36232091)
26. House of Commons Health Committee. Obesity 2004. Third Report of Session 2003-2004 Volume 1. London: House of Commons.
27. Craig R, Mindell J. editors. Health survey for England 2005: health of older people. London: National Centre for Social Research; 2007.
28. Brown CD, Higgins M, Donato KA, Rohde FC, Garrison R, Obarzanek E, et al. Body mass index and the prevalence of hypertension and dyslipidemia. Obes Res 2000;8:605-619
29. Peytremann-Bridevaux I, Santos-Eggimann B. Health correlates of overweight and obesity in adults aged 50 years and over: results from the Survey of Health, Ageing and Retirement in Europe (SHARE). Swiss Med Wkly 2008;138:261-266
30. Renehan AG, Tyson M, Egger M, Heller RF, Zwahlen M. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet 2008;371:569-578 (Pubitemid 351232031)
31. Allender S, Rayner M. The burden of overweight and obesity-related ill health in the UK. Obes Rev 2007;8:467-473 (Pubitemid 47283944)
32. Rojas-Rodriguez J, Escobar-Linares LE, Garcia- Carrasco M, Escarcega RO, Fuentes-Alexandro S, Zamora-Ustaran A. The relationship between the metabolic syndrome and energy-utilization deficit in the pathogenesis of obesity-induced osteoarthritis. Med Hypotheses 2007;69:860-868 (Pubitemid 47260664)
33. Teichtahl AJ, Wluka AE, Proietto J, Cicuttini FM. Obesity and the female sex, risk factors for knee osteoarthritis that may be attributable to systemic or local leptin biosynthesis and its cellular effects. Med Hypotheses 2005;65:312-315 (Pubitemid 40744761)
34. Liu B, Balkwill A, Banks E, Cooper C, Green J, Beral V. Relationship of height, weight and body mass index to the risk of hip and knee replacements in middle-aged women. Rheumatology (Oxford) 2007;46:861-867 (Pubitemid 47061722)
35. Young T, Peppard PE, Taheri S. Excess weight and sleep-disordered breathing. J Appl Physiol 2005;99:1592-1599
36. Bhattacharya S, Campbell DM, Liston WA, Bhattacharya S. Effect of body mass index on pregnancy outcomes in nulliparous women delivering singleton babies. BMC Public Health 2007;7:168. (Pubitemid 47222130)
37. Robinson HE, O'Connell CM, Joseph KS, McLeod NL. Maternal outcomes in pregnancies complicated by obesity. Obstet Gynecol 2005;106:1357-1364 (Pubitemid 41668957)
38. Rode L, Nilas L, Wojdemann K, Tabor A. Obesity-related complications in Danish single cephalic term pregnancies. Obstet Gynecol 2005;105:537-542 (Pubitemid 40271219)
39. Driul L, Cacciaguerra G, Citossi A, Martina MD, Peressini L, Marchesoni D. Prepregnancy body mass index and adverse pregnancy outcomes. Arch Gynecol Obstet 2008;278:23-26
40. Chu SY, Callaghan WM, Kim SY, Schmid CH, Lau J, England LJ, et al. Maternal obesity and risk of gestational diabetes mellitus. Diabetes Care 2007;30:2070-2076 (Pubitemid 47219422)
41. Raatikainen K, Heiskanen N, Heinonen S. Transition from overweight to obesity worsens pregnancy outcome in a BMI-dependent manner. Obesity (Silver Spring) 2006;14:165-171
42. De Ferranti SD, Osganian SK. Epidemiology of paediatric metabolic syndrome and type 2 diabetes mellitus. Diab Vasc Dis Res 2007;4:285-296
43. Din-Dzietham R, Liu Y, Bielo MV, Shamsa F. High blood pressure trends in children and adolescents in national surveys, 1963 to 2002. Circulation 2007;116:1488-1496
44. Schiel R, Beltschikow W, Kramer G, Stein G. Overweight, obesity and elevated blood pressure in children and adolescents. Eur J Med Res 2006;11:97-101.
45. Helmrath MA. Adolescent obesity and bariatric surgery. Surg Clin North Am 2006;86:441-454
46. Leigh-Hunt N, Rudolf M. A review of local practice regarding investigations in children attending obesity clinics and a comparison of the results with other studies. Child Care, Health Dev 2008;34:55-58
47. Falagas ME. Obesity and infection. Lancet Infect Dis 2006;6:438-446
48. Kral JG. Management: Part III - Surgery. BMJ 2006;333:900-903
49. Lean M, Finer N. Management: Part II - Drugs. BMJ 2006;333:794-797
50. Avenell A, Sattar N, Lean M. Management: Part I - Behaviour change, diet, and activity. BMJ 2006;333:740-743 (Pubitemid 44555173)
51. Avenell A, Broom J, Brown TJ, Poobalan A, Aucott L, Stearns SC, et al. Systematic review of the long-term effects and economic consequences of treatments for obesity and implications for health improvement. Health Technol Assess 2004;8:1-194.
52. Levy P, Fried M, Santini F, Finer N. The comparative effects of bariatric surgery on weight and type 2 diabetes. Obes Surg 2007;17:1248-1256 (Pubitemid 351321338)
53. Poobalan AS. Long-term weight loss effects on all cause mortality in overweight/obese populations. Obes Rev 2007;8:503-513
54. Christensen R, Bartels EM, Astrup A, Bliddal H. Effect of weight reduction in obese patients diagnosed with knee osteoarthritis: a systematic review and meta-analysis. Ann Rheum Dis 2007;66:433-439 (Pubitemid 46580460)
55. Curioni C, Andre C, Veras R. Weight reduction for primary prevention of stroke in adults with overweight or obesity. Cochrane Database Syst Rev 2006;CD006062.
56. Kral JG. Management: Part III - Surgery. BMJ 2006;333:900-903
57. Weinsier RL, Wilson LJ, Lee J. Medically safe rate of weight loss for the treatment of obesity: a guideline based on risk of gallstone formation. Am J Med 1995;98:115-117
58. Nutrition Committee of the Royal College of Physicians. Anti-obesity drugs. Guidance on appropriate prescribing and management. A report of the Nutrition Committee of the Royal College of Physicians. London: Royal College of Physicians; 2003.
59. National Institute for Health and Clinical Excellence. Rimonabant for the treatment of overweight and obese patients. No. TA144. London: The Stationery Office; 2008.
60. Lee CW, Kelly JJ, Wassef WY. Complications of bariatric surgery. Curr Opin Gastroenterol 2007;23:636-643
61. Suter M, Calmes JM, Paroz A, Giusti V. A 10-year experience with laparoscopic gastric banding for morbid obesity: high long-term complication and failure rates. Obes Surg 2006;16:829-835
62. Bueter M, Maroske J, Thalheimer A, Gasser M, Stingl T, Heimbucher J et al. Short- and long-term results of laparoscopic gastric banding for morbid obesity. Langenbeck's Archiv Surg 2008;393:199-205. (Pubitemid 351239545)
63. Scopinaro N, Gianetta E, Civalleri D, Bonalumi U, Bachi V. Bilio-pancreatic bypass for obesity: II. Initial experience in man. Br J Surg 1979;66:618-620 (Pubitemid 10224288)
64. Buchwald H. Consensus conference statement bariatric surgery for morbid obesity: health implications for patients, health professionals, and third-party payers. Surg Obes Relat Dis 2005;1:371-381
65. Jung RT, Cuschieri A. Obese patients. In: Cuschieri A, Steele RJC, Moosa AR, editors. Essential surgical practice - Volume1, 4th edn. Oxford: Butterworth Heinemann; 2000. pp. 227-240
66. Scopinaro N, Adami GF, Marinari GM, Traverso E, Camerini G, Baschieri G et al. Long-term results of biliopancreatic diversion in the treatment of morbid obesity. Acta Chir Austr 1998;30:166-171 (Pubitemid 28391107)
67. Ells L, Macknight N, Wilkinson J. Obesity Ssrgery in England: an examination of the health episode statistics 1996-2005. Obes Surg 2007;17:400-405
68. National Institute for Health and Clinical Excellence. Assumptions used in estimating a population benchmark. http://www.nice.org.uk/usingguidance/ commissioningguides/bariatric/determininglocalservicelevels/Assumptions.jsp (accessed 23 July 8 A.D.)
69. British Obesity Patient Association. http://www.bospa.org/information. aspx?page=46 (accessed 23 July 8 A.D.)
70. Colquitt J, Clegg A, Sidhu M, Royle P. Surgery for morbid obesity. Cochrane Database Syst Rev 2003; Issue 2, Art. No.: CD003641. DOI: 10.1002/14651858.CD003641.
71. Colquitt J, Clegg A, Loveman E, Royle P, Sidhu MK. Surgery for morbid obesity. Cochrane Database Syst Rev 2005; Issue 4. Art. No.: CD003641. DOI: 10.1002/14651858.CD003641.pub2.
72. Walker O, Strong M, Atchinson R, Saunders J, Abbott J. A qualitative study of primary care clinicians' views of treating childhood obesity. BMC Fam Pract 2007;8:50. (Pubitemid 47561487)
73. Agren G, Naslund I. A prospective randomized comparison of vertical banded gastroplasty (VBG), loop gastric bypass (GBY) and gastric banding (GB). Int J Obes 1989;13:595.
74. CRD. Undertaking systematic reviews of research on effectiveness. York: Centre for Reviews and Dissemination; 2001. No.4.
75. Cochrane Collaboration. Assessing risk of bias in included studies. In: Higgins J, Altman D, editors. Cochrane Handbook for Systematic Reviews of Interventions 2007.
76. Drummond MF, Jefferson TO. Guidelines for authors and peer reviewers of economic submissions to the BMJ. The BMJ Economic Evaluation Working Party. BMJ 1996;313:275-283
77. Phillips Z, Ginnelly L, Sculpher M, Claxton K, Golder S, Riemsma R et al. Review of guidelines for good practice in decision-analytic modelling in health technology assessment. Health Technol Assess 2004;8:1-172.
78. Ansay J. Vertical banded gastroplasty for morbid obesity. Laparotomy or coelioscopy? A randomized study. Obes Surg 1996;6:298.
79. Axagra JS, Goergen M, Ansay J, Bialek D, De Simone P. Intervention of Mason: laparoscopy versus laparotomy. Preliminary results of a randomized prospective series. Obes Surg 1997;7:288.
80. Miller K, Mayer E, Pichler M, Hell E. Quality-of- life outcomes of patients with the Lap-Band registered versus non-operative treatment of obesity. Preliminary results of an ongoing long-term follow-up study. Obes Surg 1997;7:280.
81. Wolf S. Gastric pacing for morbid obesity - the Magdeburg SPACE-BAND study. Int J Obes 2001;25:S28.
82. Karason K, Wallentin I, Larsson B, Sjostrom L. Effects of obesity and weight loss on left ventricular mass and relative wall thickness: survey and intervention study. BMJ 1997;315:912-916
83. Karason K, Wikstrand J, Sjostrom L, Wendelhag I. Weight loss and progression of early atherosclerosis in the carotid artery: a four-year controlled study of obese subjects. Int J Obes Relat Metab Disord 1999;23:948-956 (Pubitemid 29423938)
84. Karason K, Molgaard H, Wikstrand J, Sjostrom L. Heart rate variability in obesity and the effect of weight loss. Am J Cardiol 1999;83:1242-1247 (Pubitemid 29183925)
85. Karason K, Lindroos AK, Stenlof K, Sjostrom L. Relief of cardiorespiratory symptoms and increased physical activity after surgically induced weight loss: results from the Swedish Obese Subjects study. Arch Intern Med 2000;160:1797-1802 (Pubitemid 30418817)
86. Karlsson J, Sjostrom L, Sullivan M. Swedish obese subjects (SOS) - an intervention study of obesity. Two-year follow-up of health-related quality of life (HRQL) and eating behavior after gastric surgery for severe obesity. Int J Obes Relat Metab Disord 1998;22:113-126
87. Narbro K, Agren G, Jonsson E, Larsson B, Naslund I, Wedel H et al. Sick leave and disability pension before and after treatment for obesity: a report from the Swedish Obese Subjects (SOS) study. Int J Obes Relat Metab Disord 1999;23:619-624
88. Sjostrom CD, Lissner L, Wedel H, Sjostrom L. Reduction in incidence of diabetes, hypertension and lipid disturbances after intentional weight loss induced by bariatric surgery: the SOS Intervention Study. Obes Res 1999;7:477-484 (Pubitemid 129710611)
89. Sjostrom CD, Peltonen M, Wedel H, Sjostrom L. Differentiated long-term effects of intentional weight loss on diabetes and hypertension. Hypertension 2000;36:20-25 (Pubitemid 30602147)
90. Sjostrom CD, Peltonen M, Sjostrom L. Blood pressure and pulse pressure during long-term weight loss in the obese: the Swedish obese subjects (sos) intervention study. Obes Res 2001;9:188-195 (Pubitemid 33600279)
91. Agren G, Narbro K, Jonsson E, Naslund I, Sjostrom L, Peltonen M. Cost of in-patient care over 7 years among surgically and conventionally treated obese patients. Obes Res 2002;10:1276-1283
92. Agren G, Narbro K, Naslund I, Sjostrom L, Peltonen M. Long-term effects of weight loss on pharmaceutical costs in obese subjects. A report from the SOS intervention study. Int J Obes Relat Metab Disord 2002;26:184-192 (Pubitemid 34151195)
93. Ryden A, Karlsson J, Sullivan M, Torgerson JS, Taft C. Coping and distress: what happens after intervention? A 2-year follow-up from the Swedish Obese Subjects (SOS) study. Psychosom Med 2003;65:435-442 (Pubitemid 36628897)
94. Ryden A, Sullivan M, Torgerson JS, Karlsson J, Lindroos AK, Taft C. A comparative controlled study of personality in severe obesity: a 2-y follow-up after intervention. Int J Obes 2004;28:1485-1493 (Pubitemid 39481854)
95. Sjostrom CD. Surgery as an intervention for obesity. Results from the Swedish obese subjects study. Growth Horm IGF Res 2003;13 Suppl A:S22-S26.
96. Torgerson JS, Lindroos AK, Naslund I, Peltonen M. Gallstones, gallbladder disease, and pancreatitis: cross-sectional and 2-year data from the Swedish Obese Subjects (SOS) and SOS reference studies. Am J Gastroenterol 2003;98:1032-1041 (Pubitemid 36733764)
97. Sjostrom L, Lindroos AK, Peltonen M, Torgerson J, Bouchard C, Carlsson B et al. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med 2004;351:2683-2693 (Pubitemid 39665322)
98. Sjostrom L, Narbro K, Sjostrom CD. Bariatric surgery lowers all-cause mortality in the morbidly obese. J Fam Pract 2007;56:893.
99. Sjostrom L, Narbro K, Sjostrom CD, Karason K, Larsson B, Wedel H et al. Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med 2007;357:741-752
100. Karlsson J, Taft C, Ryden A, Sjostrom L, Sullivan M. Ten-year trends in health-related quality of life after surgical and conventional treatment for severe obesity: the SOS intervention study. Int J Obes 2007;31:1248-1261
101. Gummesson A, Sjostrom L, Lystig T, Carlsson L. Effects of bariatric surgery on cancer incidence in Swedish obese subjects. Int J Obes 2008;32:S24.
102. Stoeckli R, Chanda R, Langer I, Keller U. Changes of body weight and plasma ghrelin levels after gastric banding and gastric bypass. Obes Res 2004;12:346-350
103. Von Mach MA, Stoeckli R, Bilz S, Kraenzlin M, Langer I, Keller U. Changes in bone mineral content after surgical treatment of morbid obesity. Metabolism: Clin Exp 2004;53:918-921 (Pubitemid 38829468)
104. Christ-Crain M, Stoeckli R, Ernst A, Morgenthaler NG, Bilz S, Korbonits M et al. Effect of gastric bypass and gastric banding on proneurotensin levels in morbidly obese patients. J Clin Endocrinol Metab 2006;91:3544-3547
105. Buddeberg-Fischer B, Klaghofer R, Krug L, Buddeberg C, Muller MK, Schoeb O et al. Physical and psychosocial outcome in morbidly obese patients with and without bariatric surgery: a 4?- year follow-up. Obes Surg 2006;16:321-330
106. Vanwoert J, Michalek A, Alger S, Carter J, Howard L. A prospective randomized trial (PRT) of gastric bypass (GB) versus vertical banded gastroplasty (VBG) for morbid obesity (MO). Clin Res 1992;40:A642.
107. Angrisani L, Lorenzo M, Borrelli V. Laparoscopic adjustable gastric banding versus Roux-en-Y gastric bypass: 5-year results of a prospective randomized trial. Surg Obes Related Dis 2007;3:127-132 (Pubitemid 46444696)
108. Olbers T, Fagevik-Olsen M, Maleckas A, Lonroth H. Randomized clinical trial of laparoscopic Roux-en-Y gastric bypass versus laparoscopic vertical banded gastroplasty for obesity. Br J Surg 2005;92:557-562 (Pubitemid 40685649)
109. Olbers T, Bjorkman S, Lindroos A, Maleckas A, Lonn L, Sjostrom L et al. Body composition, dietary intake, and energy expenditure after laparoscopic Roux-en-Y gastric bypass and laparoscopic vertical banded gastroplasty: a randomized clinical trial. Ann Surg 2006;244:715-722 (Pubitemid 44629945)
110. Morino M, Toppino M, Bonnet G, del Genio G. Laparoscopic adjustable silicone gastric banding versus vertical banded gastroplasty in morbidly obese patients: a prospective randomized controlled clinical trial. Ann Surg 2003;238:835-841
111. Davila-Cervantes A, Borunda D, Dominguez-Cherit G, Gamino R, Vargas-Vorackova F, Gonzalez- Barranco J et al. Open versus laparoscopic vertical banded gastroplasty: a randomized controlled double blind trial. Obes Surg 2002;12:812-818 (Pubitemid 36135526)
112. Sundbom M, Gustavsson S. Randomized clinical trial of hand-assisted laparoscopic versus open Roux-en-Y gastric bypass for the treatment of morbid obesity. Br J Surg 2004;91:418-423 (Pubitemid 38491109)
113. Nguyen NT, Goldman C, Rosenquist CJ, Arango A, Cole CJ, Lee SJ et al. Laparoscopic versus open gastric bypass: a randomized study of outcomes, quality of life, and costs. Ann Surg 2001;234:279-289
114. Puzziferri N, ustrheim-Smith IT, Wolfe BM, Wilson SE, Nguyen NT. Three-year follow-up of a prospective randomized trial comparing laparoscopic versus open gastric bypass. Ann Surg 2006;243:181-188
115. O'Brien PE, Dixon JB, Laurie C, Skinner S, Proietto J, McNeil J et al. Treatment of mild to moderate obesity with laparoscopic adjustable gastric banding or an intensive medical program: a randomized trial.[summary for patients in Ann Intern Med. 2006 May 2;144(9):I12; PMID: 16670127]. Ann Intern Med 2006;144:625-633
116. Dixon JB, Strauss BJ, Laurie C, O'Brien PE. Changes in body composition with weight loss: obese subjects randomized to surgical and medical programs. Obesity (Silver Spring, Md) 2007;15:1187-1198 (Pubitemid 46932474)
117. Dixon JB, O'Brien PE, Playfair J, Chapman L, Schachter LM, Skinner S et al. Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial. JAMA 2008;299:316-323 (Pubitemid 351159368)
118. Bessler M, Daud A, Kim T, DiGiorgi M. Prospective randomized trial of banded versus nonbanded gastric bypass for the super obese: early results. Surg Obes Related Dis 2007;3:480-484 (Pubitemid 47055406)
119. Mingrone G, Greco AV, Giancaterini A, Scarfone A, Castagneto M, Pugeat M. Sex hormone-binding globulin levels and cardiovascular risk factors in morbidly obese subjects before and after weight reduction induced by diet or malabsorptive surgery. Athersclerosis 2002;161:455-462 (Pubitemid 34219201)
120. Howard L, Malone M, Michalek A, Carter J, Alger S, Van Woert J. Gastric bypass and vertical banded gastroplasty - a prospective randomized comparison and 5-year follow-up. Obes Surg 1995;5:55-60.
121. MacLean LD, Rhode BM, Forse RA, Nohr C. Surgery for obesity - an update of a randomized trial. Obes Surg 1995;5:145-153
122. MacLean LD, Rhode BM, Sampalis J, Forse RA. Results of the surgical treatment of obesity. Am J Surg 1993;165:155-160
123. Sugerman HJ, Starkey JV, Birkenhauer R. A randomized prospective trial of gastric bypass versus vertical banded gastroplasty for morbid obesity and their effects on sweets versus non-sweets eaters. Ann Surg 1987;205:613-624 (Pubitemid 17103382)
124. Lee WJ, Huang MT, Yu PJ, Wang W, Chen TC. Laparoscopic vertical banded gastroplasty and laparoscopic gastric bypass: a comparison. Obes Surg 2004;14:626-634 (Pubitemid 38716582)
125. Karamanakos SN, Vagenas K, Kalfarentzos F, Alexandrides TK. Weight loss, appetite suppression, and changes in fasting and postprandial ghrelin and peptide-YY levels after Roux-en-Y gastric bypass and sleeve gastrectomy: a prospective, double blind study. Ann Surg 2008;247:401-407
126. Nilsell K, Thorne A, Sjostedt S, Apelman J, Pettersson N. Prospective randomised comparison of adjustable gastric banding and vertical banded gastroplasty for morbid obesity. Eur J Surg 2001;167:504-509 (Pubitemid 32783755)
127. van Dielen FM, Soeters PB, de Brauw LM, Greve JW. Laparoscopic adjustable gastric banding versus open vertical banded gastroplasty: a prospective randomized trial. Obes Surg 2005;15:1292-1298 (Pubitemid 41565129)
128. Schouten R, Wiryasaputra D, van Dielen F, Greve J. Laparoscopic adjustable gastric banding (LAGB) versus open vertical banded gastroplasty (VBG): long-term results of a prospective randomized trial. Obes Surg 2008;18:459.
129. Himpens J, Dapri G, Cadiere GB. A prospective randomized study between laparoscopic gastric banding and laparoscopic isolated sleeve gastrectomy: results after 1 and 3 years. Obes Surg 2006;16:1450-1456 (Pubitemid 44759977)
130. Lujan JA, Frutos MD, Hernandez Q, Liron R, Cuenca JR, Valero G et al. Laparoscopic versus open gastric bypass in the treatment of morbid obesity: a randomized prospective study. Ann Surg 2004;239:433-437 (Pubitemid 38372757)
131. Westling A, Gustavsson S. Laparoscopic vs open Roux-en-Y gastric bypass: a prospective, randomized trial. Obes Surg 2001;11:284-292 (Pubitemid 32607217)
132. de Wit LT, Mathus-Vliegen L, Hey C, Rademaker B, Gouma DJ, Obertop H. Open versus laparoscopic adjustable silicone gastric banding - A prospective randomized trial for treatment of morbid obesity. Ann Surg 1999;230:800-805
133. Buddeberg-Fischer B, Klaghofer R, Sigrist S, Buddeberg C. Impact of psychosocial stress and symptoms on indication for bariatric surgery and outcome in morbidly obese patients. Obes Surg 2004;14:361-369
134. Pocard M, Treich G, Boige V, Jayr C, Terrier-Lacombe MJ, Fournier S et al. [Panniculectomy as first part of colorectal resection for cancer in a morbidly obese patient]. [French]. Ann Chirurg 2006;131:556-558
135. Mortori VM, Devereaux PJ, Adhikari NK, Burns KE, Eggert CH, Briel M et al. Randomized trials stopped early for benefit: a systematic review. JAMA 2005;294:2203-2209
136. Consten EC, Gagner M. Perioperative outcome of laparoscopic left lateral liver resection is improved by using staple line reinforcement technique: a case report. J Gastrointest Surg 2005;9:360-364
137. Torgerson JS, Sjostrom L. The Swedish Obese Subjects (SOS) study - rationale and results. Int J Obes 2001;25:s2-s4. (Pubitemid 32565145)
138. Ackroyd R, Mouiel J, Chevallier JM, Daoud F. Cost-effectiveness and budget impact of obesity surgery in patients with type-2 diabetes in three European countries. Obes Surg 2006;16:1488-1503 (Pubitemid 44759983)
139. van Mastrigt GA, van Dielen FM, Severens JL, Voss GB, Greve JW. One-year cost-effectiveness of surgical treatment of morbid obesity: vertical banded gastroplasty versus Lap-Band.[erratum appears in Obes Surg. 2006 May;16(5):682]. Obes Surg 2006;16:75-84.
140. Craig BM, Tseng DS. Cost-effectiveness of gastric bypass for severe obesity. Am J Med 2002;113:491-498 (Pubitemid 35335802)
141. Jensen C, Flum DR, ABS Consensus Conference. The costs of nonsurgical and surgical weight loss interventions: is an ounce of prevention really worth a pound of cure? Surg Obes Related Dis 2005;1:353-357
142. Salem L, Devlin A, Sullivan SD, Flum DR. Cost-effectiveness analysis of laparoscopic gastric bypass, adjustable gastric banding, and nonoperative weight loss interventions. Surg Obes Related Dis 2008;4:26-32.
143. Salem L, Jensen CC, Flum DR. Are bariatric surgical outcomes worth their cost? A systematic review. J Am Coll Surgeons 2005;200:270-278 (Pubitemid 40143219)
144. Thompson D, Edelsberg J, Colditz GA. Lifetime health and economic consequenses of obesity. Arch Intern Med 1999;159:2177-2183 (Pubitemid 29483157)
145. The Swedish Council on Technology Assessment in Health Care. Obesity, problems and interventions - a systematic review. Stockholm: SBU; 2002.
146. National Institutes of Health. Clinical guidelines on the identification, evaluation and treatment of overweight and obesity in adults. The evidence report. NIH publication No.98-4083. Bethesda MD: NIH; 1998.
147. Van Dielen FMH, Severens JS, Voss GBWE, Greve JWM. One-year cost-effectiveness of surgical treatment of morbid obesity: vertical banded gastroplasty versus Lap-Band. Obes Surg 2005;15:54.
148. Pories WJ, Swanson MS, MacDonald KG. Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus. Ann Surg 1995;222:339-350.
149. Hall JC, Watts JM, O'Brien PE, Dunstan RE, Walsh JF, Slavotinek AH et al. Gastric surgery for morbid obesity. The Adelaide Study. Ann Surg 1990;211:419-427
150. Heshka S, Greenway F, Anderson JW, Atkinson RL, Hill JO, Phinney SD et al. Self-help weight loss versus a structured commercial program after 26 weeks: a randomized controlled study. Am J Med 2000;109:282-287
151. Chapman A, Kiroff G, Game P. Laparascopic adjustable gastric banding in the treatment of obesity: a systematic literature review. Surgery 2004;135:326-351. (Pubitemid 38297385)
152. Hakim Z, Wolf A, Garrison LP. Estimating the effect of changes in body mass index on health state preferences. Pharmacoeconomics 2008;20:393-404.
153. Kral JG, Christou NV, Flum DR, Wolfe BM, Schauer PR, Gagner M et al. Medicare and bariatric surgery. Surg Obes Related Dis 2005;1:35-63.
154. Caro JJ, Stillman IO, Danel A, Getsios D, McEwan P. Cost effectiveness of rimonabant use in patients at increased cardiometabolic risk: estimates from a Markov model. J Med Econ 2007;10:239-254. (Pubitemid 47478747)
155. Erickson P, Wislon R, Shannon I. Years of healthy life. Statistical notes.Centres for Disease Control and Prevention. National Centre for Health Statistics. 7. Washington DC: US Department of Health and Human Services; 1995.
156. Cardiff Research Consortium. Health outcomes data repository. Cardiff: The MediCentre Health Park; 2008.
157. Data on the US population distribution of BMI for white women. www.soph.uab.edu/statgenetics/Research/Tables/YLL.htm. 2008. 8 A.D. February 27;
158. Agency for Healthcare Research and Quality. HCUPnet, Healthcare Cost and Utilisation Project. Rockville MD: AHRQ; 2008.
159. Jonsson B. Revealing the cost of type-2 diabetes in Europe. Diabetologia 2002;45:S5-S12. (Pubitemid 34762208)
160. Williams R, Baxter H, Bottomley J, Bibby J, Burns E, Harvey J et al. CODE-2 UK: our contribution to a European study of the costs of type 2 diabetes. Pract Diabet Int 2001;18:235-238 (Pubitemid 33026151)
161. Pories WJ, Flickinger EG, Meelheim D, Van Rij AM, Thomas FT. The effectiveness of gastric bypass over gastric partition in morbid obesity: consequence of distal gastric and duodenal exclusion. Ann Surg 1982;196:389-399
162. Beck JR, Kassirer JP, Pauker SG. A convenient Approximation of Life Expectancy (The "DEALE") I. Validation of the Method. Am J Med 1982;73:883-888
163. Warren E, Brennan A, Akehurst R. Cost-effectiveness of sibutramine in the treatment of obesity. Med Decis Making 2004;24:9-19.
164. Colditz GA, Willett WC, Rotzinsky A, Manson JE. Weight gain as a risk factor for clinical diabetes mellitus in women. Ann Intern Med 1995;122:481-486
165. Jousilahti P, Tuomilehto J, Vartiainen E, Pekkanen J, Puska P. Body weight, cardiovascular risk factors, and coronary mortality: 15-year follow-up of middle-aged men and women in Eastern Finland. Circulation 1996;93:1372-1379
166. Calle EE, Thun MJ, Petrelli JM, Rodriguez C, Heath CW. Body-mass index and mortality in a prospective cohort of U.S. adults. N Engl J Med 1999;341:1097-1105 (Pubitemid 29466221)
167. Stevens J, Cai J, Pamuk ER, Williamson DF, Thun MJ, Wood JL. The effect of age on the association between body-mass index and mortality. N Engl J Med 1998;338:1-7. (Pubitemid 28040168)
168. Andersen KM, Odell PM, Wilson WF, Kannel WB. Cardiovascular disease risk profiles. Am Heart J 1991;121:2-293.
169. Caro JJ, O'Brien JA, Hollenbeak CS, Spackman E, Ben-Joseph R, Okamoto LJ et al. Economic burden and risk of cardiovascular disease and diabetes in patients with different cardiometabolic risk profiles. Value Hlth 2007;10:S12-S20.
170. Jones DW, Chambless LE, Folsom AR, Heiss G, Hutchinson RG, Sharrett AR et al. Risk factors for coronary heart disease in African Americans: the atherosclerosis risk in communities study, 1987-1997. Archiv Intern Med 2002;162:2565-2571
171. Rexrode KM, Hennekens CH, Willett WC, Colditz GA, Stampfer MJ, Rich-Edwards JW et al. A prospective study of body mass index, weight change, and risk of stroke in women. JAMA 1997;277:1539-1545
172. Dennett SL, Boye KS, Yurgin NR. The impact of body weight on patient utilities with or without type 2 diabetes: a review of the medical literature. Value Hlth 2008;11:478-486
173. Dixon S, Currie CJ, McEwan P. Utility values for obesity and preliminary analysis of the health outcomes data repository. Exp Rev Pharmacoecon Outcomes Res 2004;4:657-665 (Pubitemid 39591900)
174. Bagust A, Beale S. Modelling EuroQol health-related utility values for diabetic complications from CODE-2 data. Hlth Econ 2005;14:217-230 (Pubitemid 40360759)
175. Kortt MA, Clarke PM. Estimating utility values for health states of overweight and obese individuals using the SF-36. QoL Res 2005;14:2177-2185
176. Tucker D, Palmer A, Valentine W, Roze S, Ray J. Counting the costs of overweight and obesity: modeling clinical and cost outcome. Curr Med Res 2006;22:575-586
177. Curtis L. Unit costs of health and social care. Canterbury: PSSRU, University of Kent, 2007.
178. Currie C, Pool C, Woehl A, Morgan CL, Cawley S, Rousculp MD, et al. The health-related utility and health-related quality of life of hospital-treated subjects with Type I and Type 2 diabetes with particular reference to differing severity of peripheral neuropathy. Diabetologia 2006;49:2272-2280 (Pubitemid 44359087)
179. Lee AJ, Morgan CL, Morrissey M, Wittrup-Jensen KU, Kennedy-Martin T, Currie CJ. Evaluation of the association between the EQ-5D index (health related utility) and body mass index (obesity) in hospital-treated people with type 1 diabetes, type 2 diabetes and with no diagnosed diabetes. Diabet Med 2005;22:1482-1486 (Pubitemid 41641152)
180. Andersen T, Backer OG, Astrup A, Quaade F. Horizontal or vertical banded gastroplasty after pretreatment with very-low-calorie formula diet: a randomized trial. Int J Obes 1987;11:295-304. (Pubitemid 17125387)
181. Amaral JF, Thompson WR. Gallbladder disease in morbidly obese. Am J Surg 1985;149:551-557
182. Deitel M, Petrov I. Incidence of symptomatic gallstones after bariatric operations. Surg Gynecol Obstet 1987;164:549-552 (Pubitemid 17091225)
183. Shiffman ML, Sugerman HJ, Kellum JM. Changes in gallbladder bile composition following gallstone formation and weight reduction. Gastroenterology 1992;103:214-221
184. Miller K, Hell E, Lang B, Lengauer E. Gallstone formation prophylaxis after gastric restrictive procedures for weight loss. a randomized double-blind placebo-controlled trial. Ann Surg 2003;238:697-702. (Pubitemid 38182261)
185. Department of Health. NHS Reference Costs 2006-2007. London: Department of Health; 2008. 8 A.D. Feb 27;
186. Ward S, Lloyd Jones M, Pandor A, Holmes M, Ara R, Ryan A et al. A systematic review and economic evaluation of statins for the prevention of coronary events. Health Technol Assess 2007;11.
187. Youman P, Wilson K, Harraf F, Kalra L. The economic burden of stroke in the United Kingdom. Pharmacoeconomics 2003;21:43-50. (Pubitemid 36332383)
188. Clegg A, Colquitt J, Sidhu M, Royle P, Walker A. Clinical and cost effectiveness of surgery for morbid obesity: a systematic review and economic evaluation. Int J Obes Related Metabol Disord: J Int Assoc Study Obes 2003;27:1167-1177 (Pubitemid 37281664)
189. Stiggelbout AM, Eijkemans MJC, Kiebert GM. The 'Utility' of the visual analog scale in medical decision making and technology assessment: is it an alternative to the time tradeoff? Int J Technol Assessment Hlthcare 1996;12:291-298
190. Wadden TA, Tsai AG. Bariatric surgery: crossing a body mass index threshold. Ann Intern Med 2006;144:689-691
191. Buchwald H, Estok R, Fahrbach K, Banel D, Sledge I. Trends in mortality in bariatric surgery: a systematic review and meta-analysis. Surgery 2007;142:621-632
192. Van Rij AM. Gastric bypass and gastric partitioning in morbid obesity: results of a controlled trial [abstract]. Aust NZ J Med Suppl 1984;14:340.
193. Mason EE, Tang S, Renquist KE, Barnes DT, Cullen JJ, Doherty C et al. A decade of change in obesity surgery. National Bariatric Surgery Registry (NBSR) Contributors. Obes Surg 1997;7:189-197
194. Wu EC, Barba CA. Current practices in the prophylaxis of venous thromboembolisms in bariatric surgery. Obes Surg 2000;10:7-13
195. 2000 Drug topics Red Book. Montvale, NJ: Medical Economics Company; 2000.
196. Heshka S, Anderson, JW, Atkinson RL, Greenway FL, Hill JO, Phinney SD, et al. Weight loss with self-help compared with a structured commercial program: a randomised trial. JAMA 2003;289:1792-1798. (Pubitemid 37430248)
197. Hakim Z, Wolf A, Garrison LP. Estimating the effect of change in body mass index on health state preference. Pharmacoeconomics 2002;20:392-404.